Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Nausea × Methadone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1 Sleep Wake Disorders 1 Pain 1 Nausea 1

Interventions

Dexamethasone 2 isatuximab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Therapeutics 1 Radiotherapy 1 Platinum 1 Ondansetron 1 Methadone 1 Granisetron 1 Electroacupuncture 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Carboplatin 1 Calcium Dobesilate 1 Aprepitant 1 Analgesia 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00930332 2024-02-12

Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain

Canadian Cancer Trials Group

Phase 1 Terminated

Nausea, Pain, Sleep Wake Disorders, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡